Laboratoires Expanscience completed the acquisition of Medtech Sublimed.

Laboratoires Expanscience, a pharmaceutical company, completed the acquisition of Medtech Sublimed, a healthcare device company. Financial terms were not disclosed. “We are very enthusiastic about this merger. After acquiring Babo Botanicals in 2018, which enabled us to accelerate our growth on the dermo-cosmetics market, this operation for external growth opens a new chapter for Expanscience. The Sublimed acquisition will enable us to diversify and innovate together to continually better support those living with chronic pain," Jean-Paul Berthomé, Laboratoires Expanscience President.